Cargando…
Correction to“Splicing factor arginine/serine‐rich 8 promotes multiple myeloma malignancy and bone lesion through alternative splicing of CACYBP and exosome‐based cellular communication”
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212051/ https://www.ncbi.nlm.nih.gov/pubmed/37228172 http://dx.doi.org/10.1002/ctm2.1282 |
Ejemplares similares
-
Splicing factor arginine/serine‐rich 8 promotes multiple myeloma malignancy and bone lesion through alternative splicing of CACYBP and exosome‐based cellular communication
por: Zhang, Yuanjiao, et al.
Publicado: (2022) -
Serine/arginine-rich splicing factors: the bridge linking alternative splicing and cancer
por: Zheng, Xiang, et al.
Publicado: (2020) -
Towards understandings of serine/arginine-rich splicing factors
por: Li, Dianyang, et al.
Publicado: (2023) -
A serine–arginine-rich (SR) splicing factor modulates alternative splicing of over a thousand genes in Toxoplasma gondii
por: Yeoh, Lee M., et al.
Publicado: (2015) -
Myelodysplasia-associated mutations in serine/arginine-rich splicing factor SRSF2 lead to alternative splicing of CDC25C
por: Skrdlant, Lindsey, et al.
Publicado: (2016)